Cerner Corp. (CERN)

0.35 0.51
NASDAQ : Technology Services
Prev Close 68.11
Open 68.31
Day Low/High 67.71 / 68.49
52 Wk Low/High 48.78 / 76.47
Volume 1.57M
Avg Volume 1.99M
Exchange NASDAQ
Shares Outstanding 318.39M
Market Cap 21.70B
EPS 1.90
P/E Ratio 37.25
Div & Yield 0.72 (0.53%)

The Friday Wrap

Be far more selective, but recognize where opportunity lies.

Cerner upgraded at Wells

Cerner Corp upgraded at UBS

Two Examples of Playing 'Bad News'

Two Examples of Playing 'Bad News'

An excessive pullback or regulatory action can create opportunity.

I'm Sure the President Means Well

But the State of the Union speech is simply not investable these days.

A Botched Opportunity for Obamacare

Handing the project to a Canadian IT company was a huge mistake.

Amazon Still in Hyper-Growth Mode

And many other big-cap stocks deliver with earnings.

Cerner upgraded at Leerink

Cerner rated new Buy at Keybanc

Cerner downgraded at Baird

A Tech Play on Obamacare

A Tech Play on Obamacare

As medical practices are forces to upgrade their systems, this company is in a good spot.

Cerner rated new Buy at Argus

Another Entry Signal to Consider

Two former leading big-cap growth names are getting 200-day support.

Cerner Corporation upgraded at Jefferies

Back In the Danger Zone

High-multiple stocks with heavy institutional ownership can hurt your long-term financial situation.

Cerner downgraded at Morgan Stanley

Cerner downgraded at Leerink

Upward Trend Not Dead

But the viability of the rally has been called into question.

An E-Health Play

An E-Health Play

Wouldn't it be great if a company could do for medical records what others are doing for smart wallets?

Identifying the Outperformers

Identifying the Outperformers

My focus is on stocks with strong fundamentals showing relative price strength that are under accumulation.

Buyers Make a Showing

Stock-pickers had a fighting chance today, and some stocks made good moves.

Here Come the Machines

The early dip gets bought, and program trading kicks in.

Get a Handle on the New Leaders

If this market breaks out, these names -- not the old guard -- will lead the market higher.

Don't Chase Growth

Don't Chase Growth

Buying a growth stock when it's overextended can result in unnecessary losses.

Cerner Will Gain on Allscripts' Pain

Even if Cerner is up sharply at the open, it's still a buy.